Lingyan Yu

1.2k total citations · 1 hit paper
65 papers, 773 citations indexed

About

Lingyan Yu is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Lingyan Yu has authored 65 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Pharmacology and 10 papers in Epidemiology. Recurrent topics in Lingyan Yu's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Epilepsy research and treatment (8 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Lingyan Yu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Epilepsy research and treatment (8 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Lingyan Yu collaborates with scholars based in China and United States. Lingyan Yu's co-authors include Zhenwei Yu, Jiping Tang, John H. Zhang, Derek Nowrangi, Tai Xiang Lu, Tian Wang, Xiaoyi Sun, Yuanyuan Lv, Mingjun Li and Tingting Sun and has published in prestigious journals such as PLoS ONE, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Lingyan Yu

53 papers receiving 770 citations

Hit Papers

Targeting epigenetic and post-translational modifications... 2025 2026 2025 5 10 15 20
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment
    2025 23 citations Jie Cao, Lingyan Yu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyan Yu China 17 252 116 92 74 69 65 773
Elham Jafari Iran 17 245 1.0× 75 0.6× 55 0.6× 37 0.5× 57 0.8× 117 893
Ting Zhao China 20 267 1.1× 81 0.7× 83 0.9× 51 0.7× 68 1.0× 74 1.0k
Rongrong Li China 14 283 1.1× 95 0.8× 83 0.9× 144 1.9× 34 0.5× 37 728
Shun Wang China 15 342 1.4× 78 0.7× 53 0.6× 126 1.7× 51 0.7× 64 1.0k
Sabrina Rahman Archie United States 14 268 1.1× 66 0.6× 40 0.4× 166 2.2× 89 1.3× 23 958
Abdullah Al Shoyaib United States 12 253 1.0× 42 0.4× 36 0.4× 114 1.5× 69 1.0× 20 779
Guocai Lu China 17 409 1.6× 33 0.3× 45 0.5× 102 1.4× 56 0.8× 43 984
Xiaotao Xu China 15 239 0.9× 30 0.3× 66 0.7× 57 0.8× 40 0.6× 27 584
Francesca Fagiani Italy 14 390 1.5× 194 1.7× 50 0.5× 59 0.8× 82 1.2× 28 1.2k
Εleni Stamoula Greece 12 306 1.2× 37 0.3× 28 0.3× 78 1.1× 48 0.7× 28 683

Countries citing papers authored by Lingyan Yu

Since Specialization
Citations

This map shows the geographic impact of Lingyan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Yu more than expected).

Fields of papers citing papers by Lingyan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Yu. The network helps show where Lingyan Yu may publish in the future.

Co-authorship network of co-authors of Lingyan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyan Yu. A scholar is included among the top collaborators of Lingyan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyan Yu. Lingyan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Chen, Yuhan, Shi‐Jun Yue, Lingyan Yu, et al.. (2025). Regulation and Function of the cGAS-STING Pathway: Mechanisms, Post-Translational Modifications, and Therapeutic Potential in Immunotherapy. Drug Design Development and Therapy. Volume 19. 1721–1739. 12 indexed citations
5.
Wang, Suhong, et al.. (2025). Cost-effectiveness of therapeutic drug monitoring of perampanel for pediatrics with epilepsy: real-world data. Frontiers in Pharmacology. 16. 1549069–1549069.
6.
7.
Yu, Lingyan, et al.. (2024). HDAC9 Deficiency Upregulates cGMP-dependent Kinase II to Mitigate Neuronal Apoptosis in Ischemic Stroke. Translational Stroke Research. 16(3). 868–881. 1 indexed citations
8.
Lv, Sha, Hongyan Jiang, Lingyan Yu, et al.. (2024). SNX14 inhibits autophagy via the PI3K/AKT/mTOR signaling cascade in breast cancer cells. Journal of Molecular Histology. 55(4). 391–401. 2 indexed citations
9.
Yu, Lingyan, et al.. (2024). Ferroptosis in Renal Cancer Therapy: A Narrative Review of Drug Candidates. Cancers. 16(18). 3131–3131. 5 indexed citations
10.
Zhu, Xueying, et al.. (2023). Efficacy of perampanel in pediatric epilepsy with known and presumed genetic etiology. Annals of Clinical and Translational Neurology. 10(8). 1374–1382. 4 indexed citations
11.
Yu, Zhenwei, Haitao Yu, Ling Zhou, et al.. (2023). Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis. International Journal of Antimicrobial Agents. 61(6). 106812–106812. 6 indexed citations
12.
Zhang, Ping, Chaoting Zhou, Xueying Ren, et al.. (2023). Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis. Redox Biology. 69. 103007–103007. 69 indexed citations
13.
Yu, Zhenwei, Haitao Yu, Ling Zhou, et al.. (2023). Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis. Frontiers in Pharmacology. 14. 1298397–1298397. 2 indexed citations
14.
Yu, Zhenwei, et al.. (2022). Prevalence and risk factors of tigecycline-induced liver injury: A multicenter retrospective study. International Journal of Infectious Diseases. 120. 59–64. 13 indexed citations
15.
Yu, Lingyan, Zhiliang Wang, Zhenwei Yu, Jianhua Feng, & Haibin Dai. (2021). Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy. Annals of Clinical and Translational Neurology. 8(8). 1764–1767.
16.
Yu, Zhenwei, et al.. (2021). Trends in Outpatient Prescribing Patterns for Ocular Topical Anti-Infectives in Six Major Areas of China, 2013–2019. Antibiotics. 10(8). 916–916. 9 indexed citations
17.
Yu, Lingyan, Wei He, Yangmin Hu, et al.. (2021). Antineoplastic prescription among patients with colorectal cancer in eight major cities of China, 2015–2019: an observational retrospective database analysis. BMJ Open. 11(10). e046166–e046166. 5 indexed citations
18.
Yu, Lingyan, et al.. (2021). Anti-seizure Medication Prescription in Adult Outpatients With Epilepsy in China, 2013–2018. Frontiers in Neurology. 12. 649589–649589. 16 indexed citations
19.
20.
Wang, Zhanmin, et al.. (2015). Study on Mechanism of Explosive Spalling of ULC Castables During Rapid Drying. 24(4). 1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elham Jafari Breakdown of academic impact, for papers by Ting Zhao Breakdown of academic impact, for papers by Rongrong Li Breakdown of academic impact, for papers by Shun Wang Breakdown of academic impact, for papers by Sabrina Rahman Archie Breakdown of academic impact, for papers by Abdullah Al Shoyaib Breakdown of academic impact, for papers by Guocai Lu Breakdown of academic impact, for papers by Xiaotao Xu Breakdown of academic impact, for papers by Francesca Fagiani Breakdown of academic impact, for papers by Εleni Stamoula
Rankless by CCL
2026